Martek Biosciences Corporation To Announce Third Quarter 2006 Results On September 6, 2006

COLUMBIA, Md., Aug. 22 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its third fiscal quarter on September 6, 2006, at approximately 4:00 p.m. Eastern Daylight Time (EDT). Following the release, at 4:45 p.m. EDT Martek will hold a conference call to discuss its third quarter results with investors. The call is expected to be approximately one hour in duration. The conference call will also be available live via the Internet. All interested parties may listen to the call by visiting Martek's web site at http://www.martekbio.com, selecting the "Investors" tab, choosing "Live Webcast" and then following the related instructions.

An archive of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 and entering pass code 21302022.

Martek Biosciences Corporation (Nasdaq: MATK - News) is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces Martek DHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula, and supplements, and ARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit www.martek.com.

Contact: Kyle Stults

Investor Relations (410) 740-0081

Source: Martek Biosciences Corporation